ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)
Product details
Registration number: SIN00388P
Classification: Prescription Only
Active ingredients: CEFTRIAXONE DISODIUM EQV CEFTRIAXONE
Strength: 1 g/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: J01DD04
HSA approval date: 27 April 1988
Manufacturer(s):
- F HOFFMANN-LA ROCHE LTD
- Siegfried Hameln GmbH (Solvent only)
Manufacturing country/countries: SWITZERLAND; GERMANY
What are the HSA registration number and classification for ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN00388P
Classification: Prescription Only
What active ingredients and strength are recorded for ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CEFTRIAXONE DISODIUM EQV CEFTRIAXONE
Strength: 1 g/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR
Who is the recorded registrant for ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR)?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- F HOFFMANN-LA ROCHE LTD
- Siegfried Hameln GmbH (Solvent only)
Manufacturing country/countries: SWITZERLAND; GERMANY
Where can I look up ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR) in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN00388P or the exact product name ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR). The general register link does not preselect this product.
What are the source dates for this ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR) record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ROCEPHIN FOR INJECTION 1 g/vial (INTRAMUSCULAR) record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN00388P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)